User profiles for Sreedhar Subramanian

Sreedhar Subramanian

Borregaard
Verified email at borregaard.com
Cited by 505

Perspective: Vitamin D deficiency and COVID‐19 severity–plausibly linked by latitude, ethnicity, impacts on cytokines, ACE2 and thrombosis

JM Rhodes, S Subramanian, E Laird… - Journal of internal …, 2021 - Wiley Online Library
Background SARS‐CoV‐2 coronavirus infection ranges from asymptomatic through to fatal
COVID‐19 characterized by a ‘cytokine storm’ and lung failure. Vitamin D deficiency has …

[HTML][HTML] low population mortality from COVID‐19 in countries south of latitude 35 degrees North supports vitamin D as a factor determining severity

JM Rhodes, S Subramanian, E Laird… - Alimentary …, 2020 - ncbi.nlm.nih.gov
Editorial: low population mortality from COVID‐19 in countries south of latitude 35 degrees
North supports vitamin D as a factor determining severity - PMC Back to Top Skip to main …

[HTML][HTML] SARS-CoV-2 vaccination for patients with inflammatory bowel disease: a British Society of Gastroenterology Inflammatory Bowel Disease section and IBD …

…, PJ Smith, A Dhar, S Subramanian… - The Lancet …, 2021 - thelancet.com
SARS-CoV-2 has caused a global health crisis and mass vaccination programmes provide
the best opportunity for controlling transmission and protecting populations. Despite the …

Vitamin D and COVID-19: evidence and recommendations for supplementation

…, J Rhodes, S Subramanian… - Royal Society …, 2020 - royalsocietypublishing.org
Vitamin D is a hormone that acts on many genes expressed by immune cells. Evidence linking
vitamin D deficiency with COVID-19 severity is circumstantial but considerable—links with …

A randomized, double-blind, placebo-controlled, parallel-group, pilot study of cannabidiol-rich botanical extract in the symptomatic treatment of ulcerative colitis

…, T Iqbal, C Nwokolo, S Subramanian… - Inflammatory bowel …, 2018 - academic.oup.com
Background Cannabidiol (CBD) exhibits anti-inflammatory properties that could improve
disease activity in inflammatory bowel disease. This proof-of-concept study assessed efficacy, …

Randomised placebo-controlled trial of rituximab (anti-CD20) in active ulcerative colitis

K Leiper, K Martin, A Ellis, S Subramanian, AJ Watson… - Gut, 2011 - gut.bmj.com
Objective To assess the safety and efficacy of the B lymphocyte (anti-CD20) antibody, rituximab,
in the treatment of steroid-resistant moderately active ulcerative colitis (UC). Methods A …

Asphaltene precipitation models: a review

S Subramanian, S Simon, J Sjöblom - Journal of Dispersion …, 2016 - Taylor & Francis
Asphaltenes are the heaviest and the most polar fractions of crude oil and are defined as a
solubility class (typically soluble in toluene but insoluble in n-alkanes like n-heptane). …

[HTML][HTML] Mercaptopurine versus placebo to prevent recurrence of Crohn's disease after surgical resection (TOPPIC): a multicentre, double-blind, randomised controlled …

…, M Smith, T Ahmad, S Subramanian… - The lancet …, 2016 - thelancet.com
Background Up to 60% of patients with Crohn's disease need intestinal resection within the
first 10 years of diagnosis, and postoperative recurrence is common. We investigated …

[HTML][HTML] Perspective: Vitamin D supplementation prevents rickets and acute respiratory infections when given as daily maintenance but not as intermittent bolus …

…, R Quinton, J Rhodes, S Subramanian… - Clinical …, 2021 - ncbi.nlm.nih.gov
The value of vitamin D supplementation in the treatment or prevention of various conditions
is often viewed with scepticism as a result of contradictory results of randomised trials. It is …

[HTML][HTML] Preventing vitamin D deficiency during the COVID-19 pandemic: UK definitions of vitamin D sufficiency and recommended supplement dose are set too low

…, R Quinton, J Rhodes, S Subramanian… - Clinical …, 2021 - ncbi.nlm.nih.gov
There is growing evidence linking vitamin D deficiency with risk of COVID-19. It is therefore
distressing that there is major disagreement about the optimal serum level for 25-…